Milestone Pharmaceuticals Inc. (MIST)
NASDAQ
Market Cap
$71.37M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
655 of 809
Rank in Industry
356 of 445
Largest Insider Buys in Sector
MIST Stock Price History Chart
MIST Stock Performance
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.
Insider Activity of Milestone Pharmaceuticals Inc.
Over the last 12 months, insiders at Milestone Pharmaceuticals Inc. have bought $0 and sold $0 worth of Milestone Pharmaceuticals Inc. stock.
On average, over the past 5 years, insiders at Milestone Pharmaceuticals Inc. have bought $8.96M and sold $7.24M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 7,000 shares for transaction amount of $32,830 was made by Bharucha David (Chief Medical Officer) on 2022‑12‑05.
List of Insider Buy and Sell Transactions, Milestone Pharmaceuticals Inc.
| 2022-12-05 | Bharucha David | Chief Medical Officer | 7,000 0.0162% | $4.69 | $32,830 | -27.47% | ||
| 2022-12-01 | Bharucha David | Chief Medical Officer | 3,000 0.007% | $4.86 | $14,580 | -29.01% | ||
| 2022-10-21 | Liebert Debra K. | director | 4,000 0.0096% | $5.26 | $21,040 | -28.57% | ||
| 2022-10-20 | Pasternak Richard C | director | 10,000 0.0232% | $5.20 | $52,000 | -30.21% | ||
| 2022-10-20 | Liebert Debra K. | director | 10,000 0.0236% | $5.29 | $52,900 | -30.21% | ||
| 2022-10-19 | Wills Robert James | director | 15,000 0.0349% | $4.93 | $73,950 | -26.01% | ||
| 2022-10-19 | TOMSICEK MICHAEL JOHN | director | 15,000 0.0376% | $5.32 | $79,800 | -26.01% | ||
| 2022-09-07 | Sale | WONG RODERICK | 1.56M 3.6651% | $8.71 | $13.56M | -56.03% | ||
| 2022-09-07 | WONG RODERICK | 1.56M 3.6651% | $8.71 | $13.56M | -56.03% | |||
| 2022-05-31 | TRUEX PAUL F | 5,000 0.0118% | $5.60 | $28,000 | -19.25% | |||
| 2020-07-29 | Sale | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10 percent owner | 500,000 1.5968% | $8.32 | $4.16M | -22.80% | |
| 2020-07-28 | Sale | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10 percent owner | 19,863 0.0675% | $8.10 | $160,890 | -15.61% | |
| 2020-03-19 | RTW INVESTMENTS, LP | 10 percent owner | 5,870 0.02% | $10.87 | $63,804 | -47.34% | ||
| 2020-03-18 | RTW INVESTMENTS, LP | 10 percent owner | 2,705 0.0091% | $10.36 | $28,029 | -45.49% | ||
| 2020-03-02 | RTW INVESTMENTS, LP | 10 percent owner | 78,263 0.3217% | $18.95 | $1.48M | -63.55% | ||
| 2020-01-13 | RTW INVESTMENTS, LP | 10 percent owner | 270,000 1.0575% | $16.25 | $4.39M | -59.47% | ||
| 2019-12-31 | RTW INVESTMENTS, LP | director | 21,438 0.0846% | $15.50 | $332,340 | -56.84% | ||
| 2019-12-30 | RTW INVESTMENTS, LP | director | 1,333 0.0054% | $15.48 | $20,638 | -55.51% | ||
| 2019-11-25 | Sale | Novo Holdings A/S | 10 percent owner | 240,000 0.8778% | $16.00 | $3.84M | -57.86% | |
| 2019-11-20 | RTW INVESTMENTS, LP | 10 percent owner | 400,000 1.4001% | $16.00 | $6.4M | -58.59% |
Insider Historical Profitability
<0.0001%
| WONG RODERICK | 4315102 12.8874% | $1.34 | 1 | 1 | <0.0001% | |
| RTW INVESTMENTS, LP | 10 percent owner | 4315102 12.8874% | $1.34 | 13 | 0 | |
| Novo Holdings A/S | 10 percent owner | 2434470 7.2707% | $1.34 | 1 | 1 | |
| BDC CAPITAL INC. | 10 percent owner | 2388088 7.1322% | $1.34 | 1 | 0 | |
| FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10 percent owner | 2254920 6.7345% | $1.34 | 1 | 2 | |
| TRUEX PAUL F | 81780 0.2442% | $1.34 | 1 | 0 | <0.0001% | |
| Wills Robert James | director | 15000 0.0448% | $1.34 | 1 | 0 | <0.0001% |
| TOMSICEK MICHAEL JOHN | director | 15000 0.0448% | $1.34 | 1 | 0 | <0.0001% |
| Bharucha David | Chief Medical Officer | 10000 0.0299% | $1.34 | 2 | 0 | <0.0001% |
| Pasternak Richard C | director | 10000 0.0299% | $1.34 | 1 | 0 | <0.0001% |
| Liebert Debra K. | director | 4000 0.0119% | $1.34 | 2 | 0 | <0.0001% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| BlackRock | $8.9M | 9.33 | 4.97M | +51.99% | +$3.04M | <0.0001 | |
| RTW Investments, LP | $5.83M | 6.11 | 3.26M | 0% | +$0 | 0.09 | |
| Millennium Management LLC | $5.11M | 5.36 | 2.86M | +91.08% | +$2.44M | <0.01 | |
| Alta Fundamental Advisers Llc | $4.24M | 4.45 | 2.37M | +41.88% | +$1.25M | 2.2 | |
| Lion Point Capital LP | $4.12M | 4.32 | 2.3M | +39.39% | +$1.16M | 7.98 | |
| Citadel Advisors LLC | $4.07M | 4.27 | 2.27M | +867.37% | +$3.65M | <0.01 | |
| OrbiMed | $3.58M | 3.76 | 2M | New | +$3.58M | 0.07 | |
| Nantahala Capital Management Llc | $3.13M | 3.29 | 1.75M | New | +$3.13M | 0.32 | |
| Stonepine Capital Management Llc | $2.62M | 2.75 | 1.46M | New | +$2.62M | 2.11 | |
| Goldman Sachs | $2.42M | 2.54 | 1.35M | 0% | +$0 | <0.0001 | |
| Bleichroeder Lp | $2.37M | 2.49 | 1.33M | 0% | +$0 | 0.63 | |
| Altium Capital Management Lp | $2.17M | 2.28 | 1.21M | New | +$2.17M | 1.01 | |
| Morgan Stanley | $1.47M | 1.54 | 819,828 | +18.92% | +$233,466.10 | <0.0001 | |
| Velan Capital | $1.16M | 1.22 | 650,000 | New | +$1.16M | 0.63 | |
| Bml Capital Management Llc | $1.08M | 1.14 | 606,145 | +37.03% | +$293,189.59 | 0.83 | |
| Monashee Investment Management LLC | $895,000.00 | 0.94 | 500,000 | New | +$895,000.00 | 0.08 | |
| Ikarian Capital LLC | $834,174.00 | 0.88 | 466,019 | +0.69% | +$5,711.89 | 0.24 | |
| Boxer Capital, LLC | $553,123.00 | 0.58 | 309,007 | 0% | +$0 | 0.03 | |
| Bank of Montreal | $786,528.00 | 0.51 | 273,100 | New | +$786,528.00 | <0.0001 | |
| Ancora Advisors Llc | $107,400.00 | 0.11 | 60,000 | +20% | +$17,900.00 | <0.01 | |
| Envestnet Asset Management Inc | $92,781.00 | 0.1 | 51,833 | +150.76% | +$55,781.73 | <0.0001 | |
| Dimensional Fund Advisors | $70,615.00 | 0.07 | 39,450 | -46.48% | -$61,314.23 | <0.0001 | |
| Boothbay Fund Management LLC | $55,094.00 | 0.06 | 30,779 | +11.57% | +$5,711.85 | <0.01 | |
| Northern Trust | $50,686.00 | 0.05 | 28,316 | -11.43% | -$6,540.71 | <0.0001 | |
| Clear Creek Financial Management | $44,750.00 | 0.05 | 25,000 | -21.26% | -$12,082.50 | 0.01 | |
| State Street | $33,872.00 | 0.04 | 18,923 | -12.44% | -$4,811.50 | <0.0001 | |
| Geode Capital Management | $31,461.00 | 0.03 | 17,576 | 0% | +$0 | <0.0001 | |
| Beta Wealth Group | $25,287.00 | 0.03 | 14,127 | 0% | +$0 | 0.02 | |
| Xtx Topco Ltd | $23,991.00 | 0.03 | 13,403 | New | +$23,991.00 | <0.01 | |
| Creative Planning | $23,413.00 | 0.03 | 13,080 | 0% | +$0 | <0.0001 | |
| Valeo Financial Advisors LLC | $16,600.00 | 0.02 | 10,000 | 0% | +$0 | <0.0001 | |
| Cetera Advisors LLC | $18,484.00 | 0.02 | 10,326 | New | +$18,484.00 | <0.0001 | |
| National Bank Of Canada Fi | $11,923.00 | 0.01 | 7,100 | +84.42% | +$5,457.71 | <0.0001 | |
| Advisor Group Holdings Inc | $10,740.00 | 0.01 | 6,000 | -57.31% | -$14,416.66 | <0.0001 | |
| UBS | $4,686.00 | 0.01 | 2,618 | New | +$4,686.00 | <0.0001 | |
| Simplex Trading Llc | $0 | <0.01 | 478 | -55.98% | -$0 | <0.0001 | |
| Barclays | $0 | <0.01 | 100 | -99.96% | -$0 | <0.0001 | |
| Qube Research & Technologies | $347.00 | <0.01 | 194 | 0% | +$0 | <0.0001 | |
| Ica Group Wealth Management Llc | $358.00 | <0.01 | 200 | 0% | +$0 | <0.0001 | |
| Oliver Lagore Vanvalin Investment Group | $179.00 | <0.01 | 100 | 0% | +$0 | <0.0001 |